This website uses cookies to help us give you the best experience when you visit our website. By continuing to use this website, you consent to our use of these cookies.

Find out more about how we use cookies and how to manage them by reading our cookie notice.

Dr.Magnus Johansson

Associate Principal Scientist, Medicinal Chemistry, CVMD iMed

Dr. Magnus J. Johansson is Associate Principal Scientist in the CVMD iMed Medicinal Chemistry department. He has a PhD focused on the preparation of chiral phosphines and asymmetric catalysis at CTH, followed by development of gold-catalyzed asymmetric cyclopropanations at University of California at Berkeley. More recently, Magnus completed a sabbatical as research fellow at the department of Chemistry and Chemical Biology at Harvard University. At AstraZeneca, his focus is on synthesis development and he has worked with several different academic collaborations, including with Stockholm University and Karolinska Institute. He actively supervises post-docs and PhD students involved in these collaborations. A common theme has been catalysis with a focus on transition metal mediated reactions. Magnus is also member of the board in the VINNOVA and Swedish Research Council funded Berzelii Center EXSELENT, and is a member of the board of the Swedish Chemical Society, Organic Chemistry division.

You are viewing: All posts Reset filters

Our Other Authors